US Patent Issued to Boehringer Ingelheim International on July 14 for "DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation" (Japanese, German Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,442, issued on July 14, was assigned to Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany).

"DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation" was invented by Thomas Friedl (Schemmerhofen, Germany), Michael Braun (Senden, Germany), Kenji Egusa (Ikeda, Japan), Hikaru Fujita (Osaka, Japan), Megumi Maruyama (Hyogo, Japan) and Takaaki Nishioka (Kobe, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and a partner drug, ...